| Item Type | Name |
|
Concept
|
Methyldopa
|
|
Concept
|
Inhibitor of Differentiation Protein 2
|
|
Concept
|
Survival Rate
|
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Sequence Analysis, RNA
|
|
Concept
|
Ursodeoxycholic Acid
|
|
Concept
|
Hepacivirus
|
|
Concept
|
Antigens, Differentiation, T-Lymphocyte
|
|
Concept
|
Down-Regulation
|
|
Concept
|
Hot Temperature
|
|
Concept
|
Cattle
|
|
Concept
|
Acetamides
|
|
Concept
|
Mutation
|
|
Concept
|
Porphyrias
|
|
Concept
|
Chromatography, Ion Exchange
|
|
Concept
|
Pilot Projects
|
|
Concept
|
DNA, Viral
|
|
Concept
|
Heme
|
|
Concept
|
Drug Screening Assays, Antitumor
|
|
Concept
|
Early Detection of Cancer
|
|
Concept
|
Reactive Oxygen Species
|
|
Concept
|
Drugs, Chinese Herbal
|
|
Concept
|
Triglycerides
|
|
Concept
|
Bone Marrow
|
|
Concept
|
Dactinomycin
|
|
Concept
|
Electrophoresis, Polyacrylamide Gel
|
|
Concept
|
Candida
|
|
Concept
|
Lymphocytes
|
|
Concept
|
Longitudinal Studies
|
|
Concept
|
Cysteine Proteinase Inhibitors
|
|
Concept
|
Gene Expression Regulation, Viral
|
|
Concept
|
alpha-MSH
|
|
Concept
|
Genes, Reporter
|
|
Concept
|
Tetrazolium Salts
|
|
Concept
|
Glucuronates
|
|
Concept
|
Adverse Drug Reaction Reporting Systems
|
|
Concept
|
Autoantibodies
|
|
Concept
|
Fatal Outcome
|
|
Concept
|
Hexachlorobenzene
|
|
Concept
|
Mephenytoin
|
|
Concept
|
Gene Expression Regulation, Enzymologic
|
|
Concept
|
Cause of Death
|
|
Concept
|
Hepatitis B Core Antigens
|
|
Concept
|
Microsatellite Repeats
|
|
Concept
|
Antibodies, Monoclonal
|
|
Concept
|
Hypergammaglobulinemia
|
|
Concept
|
Jaundice, Obstructive
|
|
Concept
|
Granzymes
|
|
Concept
|
Alkaline Phosphatase
|
|
Concept
|
Cryoglobulins
|
|
Concept
|
Demyelinating Diseases
|
|
Concept
|
Cluster Analysis
|
|
Concept
|
Hepatitis, Chronic
|
|
Concept
|
Sex Factors
|
|
Concept
|
DNA-Directed DNA Polymerase
|
|
Concept
|
Analysis of Variance
|
|
Concept
|
Weight Loss
|
|
Concept
|
Glucose-6-Phosphatase
|
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
|
Concept
|
Self Administration
|
|
Concept
|
Protease Inhibitors
|
|
Concept
|
Stress, Mechanical
|
|
Concept
|
Recombinant Fusion Proteins
|
|
Concept
|
Rheumatoid Factor
|
|
Concept
|
Abdominal Pain
|
|
Concept
|
Ellipticines
|
|
Concept
|
Embolism, Air
|
|
Concept
|
Cyclosporine
|
|
Concept
|
Response Elements
|
|
Concept
|
Oxidation-Reduction
|
|
Concept
|
Chromosomes, Human, Pair 19
|
|
Concept
|
Sequence Alignment
|
|
Concept
|
Cytochrome P-450 CYP1A1
|
|
Concept
|
Arthralgia
|
|
Concept
|
Pulmonary Embolism
|
|
Concept
|
Leukocytes, Mononuclear
|
|
Concept
|
alpha-Fetoproteins
|
|
Concept
|
tert-Butylhydroperoxide
|
|
Concept
|
Genome, Human
|
|
Concept
|
Transduction, Genetic
|
|
Concept
|
Protein Tyrosine Phosphatases
|
|
Concept
|
Mifepristone
|
|
Concept
|
Polychlorinated Biphenyls
|
|
Concept
|
Interferon-alpha
|
|
Concept
|
Carcinoma, Hepatocellular
|
|
Concept
|
Genotype
|
|
Concept
|
Interleukin-8
|
|
Concept
|
Polymorphism, Genetic
|
|
Concept
|
beta-Thalassemia
|
|
Concept
|
Administration, Oral
|
|
Concept
|
Liver Function Tests
|
|
Concept
|
Ketone Oxidoreductases
|
|
Concept
|
Depression
|
|
Concept
|
Protein Kinase Inhibitors
|
|
Concept
|
Porphobilinogen Synthase
|
|
Concept
|
Hyperinsulinism
|
|
Concept
|
Chick Embryo
|
|
Concept
|
Genetic Testing
|
|
Concept
|
Confidence Intervals
|
|
Concept
|
Interferons
|
|
Concept
|
Thrombocytopenia
|
|
Concept
|
Amino Acid Substitution
|
|
Concept
|
Lymphocyte Function-Associated Antigen-1
|
|
Concept
|
Malates
|
|
Concept
|
Glucose-6-Phosphate Isomerase
|
|
Concept
|
Antibodies, Antinuclear
|
|
Concept
|
Erythrocytes
|
|
Concept
|
Chi-Square Distribution
|
|
Concept
|
Interviews as Topic
|
|
Concept
|
Binding, Competitive
|
|
Concept
|
Blotting, Northern
|
|
Concept
|
Leukopenia
|
|
Concept
|
Feasibility Studies
|
|
Concept
|
Thiazolidinediones
|
|
Concept
|
Dermatitis, Phototoxic
|
|
Concept
|
Genes
|
|
Concept
|
Genetic Diseases, X-Linked
|
|
Concept
|
Camellia sinensis
|
|
Concept
|
Models, Immunological
|
|
Concept
|
Double-Blind Method
|
|
Concept
|
Hepatitis, Animal
|
|
Concept
|
Algorithms
|
|
Concept
|
Lipase
|
|
Concept
|
Protoporphyrins
|
|
Concept
|
Porphyria, Variegate
|
|
Concept
|
Pyrrolidines
|
|
Concept
|
Patient Education as Topic
|
|
Concept
|
Saline Solution, Hypertonic
|
|
Concept
|
Random Allocation
|
|
Concept
|
Renal Insufficiency
|
|
Concept
|
Rectal Prolapse
|
|
Concept
|
NADH Dehydrogenase
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Galactose
|
|
Concept
|
Antibodies
|
|
Concept
|
Iran
|
|
Concept
|
Databases, Genetic
|
|
Concept
|
Epitope Mapping
|
|
Concept
|
Lipid Peroxidation
|
|
Concept
|
Fatty Acids, Monounsaturated
|
|
Concept
|
Antiviral Agents
|
|
Concept
|
Jaundice
|
|
Concept
|
Hydrogen Peroxide
|
|
Concept
|
Polybrominated Biphenyls
|
|
Concept
|
Antibodies, Viral
|
|
Concept
|
Blotting, Western
|
|
Concept
|
Histocompatibility Antigens Class I
|
|
Concept
|
Pancreatic Neoplasms
|
|
Concept
|
3T3 Cells
|
|
Concept
|
Regression Analysis
|
|
Concept
|
Antigens, Differentiation, Myelomonocytic
|
|
Concept
|
Guillain-Barre Syndrome
|
|
Concept
|
Injections, Subcutaneous
|
|
Concept
|
Enhancer Elements, Genetic
|
|
Concept
|
Diabetes Mellitus
|
|
Concept
|
Hydrocortisone
|
|
Concept
|
Thiophenes
|
|
Concept
|
Genetic Predisposition to Disease
|
|
Concept
|
Pyrimidines
|
|
Concept
|
Diagnostic Imaging
|
|
Concept
|
Triazoles
|
|
Concept
|
T-Lymphocyte Subsets
|
|
Concept
|
Intestinal Absorption
|
|
Concept
|
Acetylcysteine
|
|
Concept
|
Pathology, Molecular
|
|
Concept
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors
|
|
Concept
|
Biopsy
|
|
Concept
|
Dithiothreitol
|
|
Concept
|
Cardiac Output
|
|
Concept
|
Sphingosine
|
|
Concept
|
Immunoglobulins
|
|
Concept
|
Area Under Curve
|
|
Concept
|
Clinical Protocols
|
|
Concept
|
Infusions, Intravenous
|
|
Concept
|
Up-Regulation
|
|
Concept
|
Biopsy, Needle
|
|
Concept
|
Durapatite
|
|
Concept
|
Early Diagnosis
|
|
Concept
|
Ketoglutaric Acids
|
|
Concept
|
Fibrinolysis
|
|
Concept
|
Stroke Volume
|
|
Concept
|
Logistic Models
|
|
Concept
|
Chlorobenzenes
|
|
Concept
|
Homozygote
|
|
Concept
|
Phenylephrine
|
|
Concept
|
Hepatitis E
|
|
Concept
|
Genetic Techniques
|
|
Concept
|
Hepatitis, Viral, Human
|
|
Concept
|
Protein Synthesis Inhibitors
|
|
Concept
|
Radioimmunoassay
|
|
Concept
|
Porphyria, Hepatoerythropoietic
|
|
Concept
|
Enzyme Induction
|
|
Concept
|
Procollagen
|
|
Concept
|
Platelet Glycoprotein GPIb-IX Complex
|
|
Concept
|
Anemia
|
|
Concept
|
Forecasting
|
|
Concept
|
Clinical Trials as Topic
|
|
Concept
|
Intestinal Polyps
|
|
Concept
|
Bone Marrow Cells
|
|
Concept
|
Genetic Variation
|
|
Concept
|
Immunoenzyme Techniques
|
|
Concept
|
Hepatitis C
|
|
Concept
|
Statistics, Nonparametric
|
|
Concept
|
Histocytochemistry
|
|
Concept
|
2-Acetylaminofluorene
|
|
Concept
|
Kinetics
|
|
Concept
|
Hep G2 Cells
|
|
Concept
|
Biological Transport, Active
|
|
Concept
|
Isoenzymes
|
|
Concept
|
Lung Diseases
|
|
Concept
|
Transcription, Genetic
|
|
Concept
|
Nitrogen
|
|
Concept
|
Pyrroles
|
|
Concept
|
Microscopy, Confocal
|
|
Concept
|
Fat Necrosis
|
|
Concept
|
Tumor Necrosis Factor-alpha
|
|
Concept
|
Drug Carriers
|
|
Concept
|
Methemoglobin
|
|
Concept
|
Gene Expression Regulation, Developmental
|
|
Concept
|
Chromatography, High Pressure Liquid
|
|
Concept
|
Lipid Peroxides
|
|
Concept
|
Splanchnic Circulation
|
|
Concept
|
Haplotypes
|
|
Concept
|
Serum Albumin
|
|
Concept
|
Antipyrine
|
|
Concept
|
Hydroxyapatites
|
|
Concept
|
Matrix Metalloproteinase 9
|
|
Concept
|
Fatty Liver, Alcoholic
|
|
Concept
|
Estrogens
|
|
Concept
|
Exons
|
|
Concept
|
Diabetes Mellitus, Type 2
|
|
Concept
|
Glutethimide
|
|
Concept
|
Treatment Failure
|
|
Concept
|
Mutagenesis, Insertional
|
|
Concept
|
Regulatory Sequences, Nucleic Acid
|
|
Concept
|
HLA-DR Antigens
|
|
Concept
|
Hepatitis B e Antigens
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Gene Expression Regulation
|
|
Concept
|
Liver Glycogen
|
|
Concept
|
Platelet Count
|
|
Concept
|
Transferrin
|
|
Concept
|
Sequence Deletion
|
|
Concept
|
Gastric Bypass
|
|
Concept
|
Isoniazid
|
|
Concept
|
Models, Statistical
|
|
Concept
|
Interleukins
|
|
Concept
|
Hepatitis B, Chronic
|
|
Concept
|
Multiple Chemical Sensitivity
|
|
Concept
|
Liver Neoplasms
|
|
Concept
|
T-Lymphocytes
|
|
Concept
|
Tetrapyrroles
|
|
Concept
|
Alcoholism
|
|
Concept
|
Multivariate Analysis
|
|
Concept
|
Oxygen
|
|
Concept
|
Phosphoric Monoester Hydrolases
|
|
Concept
|
Antigens, CD
|
|
Concept
|
Chickens
|
|
Concept
|
MAP Kinase Kinase 1
|
|
Concept
|
Serotonin Plasma Membrane Transport Proteins
|
|
Concept
|
Biliverdine
|
|
Concept
|
Succinates
|
|
Concept
|
DNA Mutational Analysis
|
|
Concept
|
Hydralazine
|
|
Concept
|
Enzyme Repression
|
|
Concept
|
Alcohols
|
|
Concept
|
Immunoglobulin G
|
|
Concept
|
Xenograft Model Antitumor Assays
|
|
Concept
|
Nucleic Acid Synthesis Inhibitors
|
|
Concept
|
Severity of Illness Index
|
|
Concept
|
Cell Proliferation
|
|
Concept
|
Gene Expression Profiling
|
|
Concept
|
Coproporphyria, Hereditary
|
|
Concept
|
Cytokines
|
|
Concept
|
Body Mass Index
|
|
Concept
|
Nuclear Receptor Subfamily 1, Group D, Member 1
|
|
Concept
|
Piperazines
|
|
Concept
|
Hepatitis E virus
|
|
Concept
|
Enzyme-Linked Immunosorbent Assay
|
|
Concept
|
Age Factors
|
|
Concept
|
Neutrophils
|
|
Concept
|
T-Lymphocytes, Cytotoxic
|
|
Concept
|
Disease Models, Animal
|
|
Concept
|
Intestinal Mucosa
|
|
Concept
|
Haptoglobins
|
|
Concept
|
Liver Circulation
|
|
Concept
|
Drug Administration Schedule
|
|
Concept
|
Drainage
|
|
Concept
|
Drug Resistance, Viral
|
|
Concept
|
Interleukin-10
|
|
Concept
|
Somatotypes
|
|
Concept
|
Health Surveys
|
|
Concept
|
Hepatitis, Alcoholic
|
|
Concept
|
Sequence Analysis, DNA
|
|
Concept
|
Cations
|
|
Concept
|
Databases, Factual
|
|
Concept
|
Fluoresceins
|
|
Concept
|
Thiazoles
|
|
Concept
|
Transforming Growth Factor beta
|
|
Concept
|
Microscopy, Electron
|
|
Concept
|
Taq Polymerase
|
|
Concept
|
Interferon-beta
|
|
Concept
|
Methionine Sulfoximine
|
|
Concept
|
Androgens
|
|
Concept
|
Nutrition Assessment
|
|
Concept
|
Lysophospholipids
|
|
Concept
|
Rectal Neoplasms
|
|
Concept
|
Blood Pressure
|
|
Concept
|
Protein Processing, Post-Translational
|
|
Concept
|
Genetic Association Studies
|
|
Concept
|
Interferon-gamma
|
|
Concept
|
Matrix Metalloproteinase 8
|
|
Concept
|
Phenobarbital
|
|
Concept
|
Vasoconstriction
|
|
Concept
|
Gene Regulatory Networks
|
|
Concept
|
Serum Albumin, Bovine
|
|
Concept
|
Drug Eruptions
|
|
Concept
|
Colonoscopy
|
|
Concept
|
Restriction Mapping
|
|
Concept
|
Flow Cytometry
|
|
Concept
|
Glomerulonephritis, Membranoproliferative
|
|
Concept
|
Incidence
|
|
Concept
|
Complementarity Determining Regions
|
|
Concept
|
Introns
|
|
Concept
|
Proportional Hazards Models
|
|
Concept
|
Glutamic Acid
|
|
Concept
|
Erythropoietin
|
|
Concept
|
Mitogen-Activated Protein Kinases
|
|
Concept
|
Heterozygote
|
|
Concept
|
Insulin Receptor Substrate Proteins
|
|
Concept
|
Metalloporphyrins
|
|
Concept
|
Calcium-Calmodulin-Dependent Protein Kinases
|
|
Concept
|
Anemia, Hemolytic, Autoimmune
|
|
Concept
|
Hepatitis B virus
|
|
Concept
|
Liver Regeneration
|
|
Concept
|
p38 Mitogen-Activated Protein Kinases
|
|
Concept
|
Magnetic Resonance Imaging
|
|
Concept
|
Gene Expression
|
|
Concept
|
Hematologic Neoplasms
|
|
Concept
|
Drug Therapy, Combination
|
|
Concept
|
Intercellular Adhesion Molecule-1
|
|
Concept
|
Drug Costs
|
|
Concept
|
Mutagenesis, Site-Directed
|
|
Concept
|
Cholangiopancreatography, Endoscopic Retrograde
|
|
Concept
|
RNA Interference
|
|
Concept
|
Piperonyl Butoxide
|
|
Concept
|
Mitochondrial Membranes
|
|
Concept
|
Isoproterenol
|
|
Concept
|
Practice Guidelines as Topic
|
|
Concept
|
Polymorphism, Single Nucleotide
|
|
Concept
|
Fluorescent Antibody Technique
|
|
Concept
|
Porphyrias, Hepatic
|
|
Concept
|
Telomere
|
|
Concept
|
Body Weight
|
|
Concept
|
CD8-Positive T-Lymphocytes
|
|
Concept
|
Lymphocyte Count
|
|
Concept
|
Polyethylene Glycols
|
|
Concept
|
Atenolol
|
|
Concept
|
Sensitivity and Specificity
|
|
Concept
|
Alcohol Drinking
|
|
Concept
|
Vascular Cell Adhesion Molecule-1
|
|
Concept
|
Endothelium, Vascular
|
|
Concept
|
Kupffer Cells
|
|
Concept
|
Adenomatous Polyps
|
|
Concept
|
Hemin
|
|
Concept
|
Registries
|
|
Concept
|
Hemochromatosis
|
|
Concept
|
Ceruloplasmin
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
DNA Fragmentation
|
|
Concept
|
Macrophages
|
|
Concept
|
Vascular Resistance
|
|
Concept
|
Porphobilinogen
|
|
Concept
|
Osteoblasts
|
|
Concept
|
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)
|
|
Concept
|
Chemokine CCL3
|
|
Concept
|
Genomics
|
|
Concept
|
TATA Box
|
|
Concept
|
Myoglobin
|
|
Concept
|
Cycloheximide
|
|
Concept
|
Porphyrins
|
|
Concept
|
Methoxamine
|
|
Concept
|
Gene Library
|
|
Concept
|
Prevalence
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
Chemokines, CXC
|
|
Concept
|
Hemodynamics
|
|
Concept
|
Chemokine CCL2
|
|
Concept
|
Cations, Divalent
|
|
Concept
|
Gene Expression Regulation, Neoplastic
|
|
Concept
|
Predictive Value of Tests
|
|
Concept
|
Reproducibility of Results
|
|
Concept
|
Acetylgalactosamine
|
|
Concept
|
Succinic Acid
|
|
Concept
|
JNK Mitogen-Activated Protein Kinases
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Electron Transport
|
|
Concept
|
Hyaluronic Acid
|
|
Concept
|
3' Untranslated Regions
|
|
Concept
|
Liver Failure
|
|
Concept
|
Porphyria, Acute Intermittent
|
|
Concept
|
Cross-Sectional Studies
|
|
Concept
|
Colonic Polyps
|
|
Concept
|
Sterol Esterase
|
|
Concept
|
Allylisopropylacetamide
|
|
Concept
|
Hepatitis, Autoimmune
|
|
Concept
|
Limit of Detection
|
|
Concept
|
Collagen
|
|
Concept
|
Ethanol
|
|
Concept
|
alpha 1-Antitrypsin Deficiency
|
|
Concept
|
Interleukin-6
|
|
Concept
|
Hemoglobins
|
|
Concept
|
Genistein
|
|
Concept
|
Drug Resistance, Neoplasm
|
|
Concept
|
Spleen
|
|
Concept
|
Enteral Nutrition
|
|
Concept
|
Nitrofurantoin
|
|
Concept
|
Randomized Controlled Trials as Topic
|
|
Concept
|
Coproporphyrins
|
|
Concept
|
Free Radicals
|
|
Concept
|
Acetates
|
|
Concept
|
Genome-Wide Association Study
|
|
Concept
|
Vasodilation
|
|
Concept
|
Drug Implants
|
|
Concept
|
Multiple Sclerosis
|
|
Concept
|
Immunoelectrophoresis
|
|
Concept
|
HLA Antigens
|
|
Concept
|
Proteomics
|
|
Concept
|
Creatinine
|
|
Concept
|
Enzyme Inhibitors
|
|
Concept
|
Amoxicillin-Potassium Clavulanate Combination
|
|
Concept
|
Tomography, X-Ray Computed
|
|
Concept
|
Graft Survival
|
|
Concept
|
Hepatitis B
|
|
Concept
|
Idarubicin
|
|
Concept
|
STAT1 Transcription Factor
|
|
Concept
|
Oligonucleotide Array Sequence Analysis
|
|
Concept
|
B-Lymphocytes
|
|
Concept
|
Deferoxamine
|
|
Concept
|
Transfection
|
|
Concept
|
Nitrilotriacetic Acid
|
|
Concept
|
Gene Frequency
|
|
Concept
|
STAT2 Transcription Factor
|
|
Concept
|
Buthionine Sulfoximine
|
|
Concept
|
Polymerase Chain Reaction
|
|
Concept
|
Probability
|
|
Concept
|
Sunlight
|
|
Concept
|
Liver Failure, Acute
|
|
Concept
|
Colon
|
|
Concept
|
Ultrasonography
|
|
Concept
|
Hypercholesterolemia
|
|
Concept
|
Gene Deletion
|
|
Concept
|
Hepatitis C, Chronic
|
|
Concept
|
Risk Assessment
|
|
Concept
|
In Situ Hybridization, Fluorescence
|
|
Concept
|
Genetic Vectors
|
|
Concept
|
Mutation, Missense
|
|
Concept
|
MicroRNAs
|
|
Concept
|
Porphyria Cutanea Tarda
|
|
Concept
|
Hydrogen-Ion Concentration
|
|
Concept
|
Risk Factors
|
|
Concept
|
Bilirubin
|
|
Concept
|
Camphor
|
|
Concept
|
Tangier Disease
|
|
Concept
|
Portasystemic Shunt, Surgical
|
|
Concept
|
Promoter Regions, Genetic
|
|
Concept
|
Recombination, Genetic
|
|
Concept
|
Gene Silencing
|
|
Concept
|
Protoporphyria, Erythropoietic
|
|
Concept
|
Base Sequence
|
|
Concept
|
Alleles
|
|
Concept
|
Genes, Recessive
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Cloning, Molecular
|
|
Concept
|
Templates, Genetic
|
|
Concept
|
Killer Cells, Natural
|
|
Concept
|
Interferon Type I
|
|
Concept
|
Gene Knockdown Techniques
|
|
Concept
|
3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide)
|
|
Concept
|
Genome, Viral
|
|
Concept
|
Immunohistochemistry
|
|
Concept
|
Choline
|
|
Concept
|
Drug Combinations
|
|
Concept
|
Comorbidity
|
|
Concept
|
ROC Curve
|
|
Concept
|
Renal Insufficiency, Chronic
|
|
Concept
|
Injections, Intravenous
|
|
Concept
|
Protein Engineering
|
|
Concept
|
Immunoblotting
|
|
Concept
|
Cryoglobulinemia
|
|
Concept
|
Chemokine CXCL12
|
|
Concept
|
Genes, MHC Class I
|
|
Concept
|
Hemopexin
|
|
Concept
|
Uroporphyrins
|
|
Academic Article
|
Iron and the liver.
|
|
Academic Article
|
Osteocalcin and bone alkaline phosphatase in the serum of women with liver disease.
|
|
Academic Article
|
The porphyrias.
|
|
Academic Article
|
Mechanism of iron potentiation of hepatic uroporphyria: studies in cultured chick embryo liver cells.
|
|
Academic Article
|
Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda.
|
|
Academic Article
|
Hepatic microsomal function in rats with chronic dietary iron overload.
|
|
Academic Article
|
Uroporphyrin accumulation produced by halogenated biphenyls in chick-embryo hepatocytes. Reversal of the accumulation by piperonyl butoxide.
|
|
Academic Article
|
Hepatic heme and drug metabolism in rats with chronic mountain sickness.
|
|
Academic Article
|
Role of cytochrome P-450 in porphyria caused by halogenated aromatic compounds.
|
|
Academic Article
|
Regulation of hepatic haem metabolism. Disparate mechanisms of induction of haem oxygenase by drugs and metals.
|
|
Academic Article
|
Tryptophan 2,3-dioxygenase in chick embryo hepatocytes: studies in ovo and in culture.
|
|
Academic Article
|
Microassay of heme oxygenase by high-performance liquid chromatography: application to assay of needle biopsies of human liver.
|
|
Academic Article
|
Haem synthesis from exogenous 5-aminolaevulinate in cultured chick-embryo hepatocytes. Effects of inducers of cytochromes P-450.
|
|
Academic Article
|
Effects of therapeutic paracentesis on systemic and hepatic hemodynamics and on renal and hormonal function.
|
|
Academic Article
|
Induction of porphyria in cultured chick-embryo hepatocytes by halogenated aromatic compounds.
|
|
Academic Article
|
Hepatic heme synthesis in a new model of experimental hemochromatosis: studies in rats fed finely divided elemental iron.
|
|
Academic Article
|
High-performance liquid chromatographic separation and quantitation of tetrapyrroles from biological materials.
|
|
Academic Article
|
Induction of 5-aminolaevulinate synthase by two- to five-carbon alcohols in cultured chick-embryo hepatocytes. Relationship to induction of cytochrome P-450.
|
|
Academic Article
|
Fatal liver failure in protoporphyria. Synergism between ethanol excess and the genetic defect.
|
|
Academic Article
|
Severe liver injury due to phenelzine with unique hepatic deposition of extracellular material.
|
|
Academic Article
|
Cytochrome P450 of small intestinal epithelial cells. Immunochemical characterization of the increase in cytochrome P450 caused by phenobarbital.
|
|
Academic Article
|
Increased glutathione in cultured hepatocytes associated with induction of cytochrome P-450. Lack of effect of glutathione depletion on induction of cytochrome P-450 and delta-aminolevulinate synthase.
|
|
Academic Article
|
Effect of uroporphyrin on the spectral measurement of cytochrome P450.
|
|
Academic Article
|
Effect of hemochromatosis on hepatic cytochrome P450 and antipyrine metabolism in humans.
|
|
Academic Article
|
Colonic mucosal appearance of Tangier disease in a new patient.
|
|
Academic Article
|
The post-translational processing of myeloperoxidase is regulated by the availability of heme.
|
|
Academic Article
|
Nutritional supplementation in chronic liver disease: an analytical review.
|
|
Academic Article
|
Iron and chronic viral hepatitis: emerging evidence for an important interaction.
|
|
Academic Article
|
Haemopexin and uptake of haem by liver cells.
|
|
Academic Article
|
Regulation of expression of the human heme oxygenase-1 gene in transfected chick embryo liver cell cultures.
|
|
Academic Article
|
Molecular cloning, characterization, and expression of the chicken heme oxygenase-1 gene in transfected primary cultures of chick embryo liver cells.
|
|
Academic Article
|
Mechanism of sodium arsenite-mediated induction of heme oxygenase-1 in hepatoma cells. Role of mitogen-activated protein kinases.
|
|
Academic Article
|
Management of acute attacks in the porphyrias.
|
|
Academic Article
|
Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques.
|
|
Academic Article
|
Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis.
|
|
Academic Article
|
Effects of phenylarsine oxide on expression of heme oxygenase-1 reporter constructs in transiently transfected cultures of chick embryo liver cells.
|
|
Academic Article
|
Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial.
|
|
Academic Article
|
Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial.
|
|
Academic Article
|
Induction of the heme oxygenase-1 gene by metalloporphyrins.
|
|
Academic Article
|
Role of HFE gene mutations in liver diseases other than hereditary hemochromatosis.
|
|
Academic Article
|
Hepatic iron concentration and total body iron stores in thalassemia major.
|
|
Academic Article
|
Increased heme oxygenase activity in splanchnic organs from portal hypertensive rats: role in modulating mesenteric vascular reactivity.
|
|
Academic Article
|
Urea and hypertonicity increase expression of heme oxygenase-1 in murine renal medullary cells.
|
|
Academic Article
|
Mapping of the chick heme oxygenase-1 proximal promoter for responsiveness to metalloporphyrins.
|
|
Academic Article
|
Management of nonalcoholic steatohepatitis: an analytic review.
|
|
Academic Article
|
Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C.
|
|
Academic Article
|
Optimal management of nonalcoholic fatty liver/steatohepatitis.
|
|
Academic Article
|
Iron as a co-morbid factor in nonhemochromatotic liver disease.
|
|
Academic Article
|
Hepatic porphyrias: diagnosis and management.
|
|
Academic Article
|
Haem repression of the housekeeping 5-aminolaevulinic acid synthase gene in the hepatoma cell line LMH.
|
|
Academic Article
|
Neurovisceral porphyrias: what a hematologist needs to know.
|
|
Academic Article
|
Hepatotoxicity due to extracts of Chinese green tea (Camellia sinensis): a growing concern.
|
|
Academic Article
|
HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial.
|
|
Academic Article
|
Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis.
|
|
Academic Article
|
Serum measures of iron status and HFE gene mutations in patients with hepatitis B virus infection.
|
|
Academic Article
|
Tissue-specific expression of ALA synthase-1 and heme oxygenase-1 and their expression in livers of rats chronically exposed to ethanol.
|
|
Academic Article
|
Case records of the Massachusetts General Hospital. Case 20-2008. A 57-year-old woman with abdominal pain and weakness after gastric bypass surgery.
|
|
Academic Article
|
Effects of silymarin on hepatitis C virus and haem oxygenase-1 gene expression in human hepatoma cells.
|
|
Academic Article
|
Differential regulation of human ALAS1 mRNA and protein levels by heme and cobalt protoporphyrin.
|
|
Academic Article
|
Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.
|
|
Academic Article
|
Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.
|
|
Academic Article
|
Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct.
|
|
Academic Article
|
Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
|
|
Academic Article
|
Iron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cells.
|
|
Academic Article
|
Changes in quality of life and sexual health are associated with low-dose peginterferon therapy and disease progression in patients with chronic hepatitis C.
|
|
Academic Article
|
MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins.
|
|
Academic Article
|
Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network.
|
|
Academic Article
|
Parallel microRNA and mRNA expression profiling of (genotype 1b) human hepatoma cells expressing hepatitis C virus.
|
|
Academic Article
|
Metabolic and functional differences between brain and spinal cord mitochondria underlie different predisposition to pathology.
|
|
Academic Article
|
A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C.
|
|
Academic Article
|
Lon peptidase 1 (LONP1)-dependent breakdown of mitochondrial 5-aminolevulinic acid synthase protein by heme in human liver cells.
|
|
Academic Article
|
YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C.
|
|
Academic Article
|
Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.
|
|
Academic Article
|
Serum proteomic profiling in patients with drug-induced liver injury.
|
|
Academic Article
|
Hepatitis C, porphyria cutanea tarda and liver iron: an update.
|
|
Academic Article
|
The let-7 microRNA enhances heme oxygenase-1 by suppressing Bach1 and attenuates oxidant injury in human hepatocytes.
|
|
Academic Article
|
Acute liver injury due to flavocoxid (Limbrel), a medical food for osteoarthritis: a case series.
|
|
Academic Article
|
Risk factors for porphyria cutanea tarda -the iron/HFE connection.
|
|
Academic Article
|
Cytoskeletal proteins: shaping progression of hepatitis C virus-induced liver disease.
|
|
Academic Article
|
Loss-of-function ferrochelatase and gain-of-function erythroid-specific 5-aminolevulinate synthase mutations causing erythropoietic protoporphyria and x-linked protoporphyria in North American patients reveal novel mutations and a high prevalence of X-linked protoporphyria.
|
|
Academic Article
|
Circadian rhythms in acute intermittent porphyria--a pilot study.
|
|
Academic Article
|
Porphyrin and heme metabolism and the porphyrias.
|
|
Academic Article
|
Intravenous interferon administered during liver transplantation is not effective in preventing hepatitis C reinfection.
|
|
Academic Article
|
Proteomic strategy for probing complementary lethality of kinase inhibitors against pancreatic cancer.
|
|
Academic Article
|
Drug-induced liver injury with autoimmune features.
|
|
Academic Article
|
Hepatitis B and liver transplantation: molecular and clinical features that influence recurrence and outcome.
|
|
Academic Article
|
MiR-122 decreases HCV entry into hepatocytes through binding to the 3' UTR of OCLN mRNA.
|
|
Academic Article
|
Afamelanotide for Erythropoietic Protoporphyria.
|
|
Academic Article
|
Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis.
|
|
Academic Article
|
Acute Porphyrias.
|
|
Academic Article
|
Hepatotoxicity Associated with the Use of Anti-TNF-a Agents.
|
|
Academic Article
|
Profiles of miRNAs in serum in severe acute drug induced liver injury and their prognostic significance.
|
|
Academic Article
|
BMP4 promotes metastasis of hepatocellular carcinoma by an induction of epithelial-mesenchymal transition via upregulating ID2.
|
|
Academic Article
|
Associations of gender and a proxy of female menopausal status with histological features of drug-induced liver injury.
|
|
Academic Article
|
Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response.
|
|
Grant
|
Regulation of Hepatic Heme Metabolism
|
|
Academic Article
|
Porphyria.
|
|
Academic Article
|
miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling.
|
|
Academic Article
|
Porphyria.
|
|
Academic Article
|
Tumour-specific amplitude-modulated radiofrequency electromagnetic fields induce differentiation of hepatocellular carcinoma via targeting Cav3.2?T-type voltage-gated calcium channels and Ca2+ influx.
|
|
Academic Article
|
Correction: Cytokine profiles in acute liver injury-Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group.
|
|
Academic Article
|
Porphyrin-Induced Protein Oxidation and Aggregation as a Mechanism of Porphyria-Associated Cell Injury.
|
|
Academic Article
|
Cytokine profiles in acute liver injury-Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group.
|
|
Academic Article
|
Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs).
|
|
Academic Article
|
International Porphyria Molecular Diagnostic Collaborative: an evidence-based database of verified pathogenic and benign variants for the porphyrias.
|
|
Academic Article
|
Genetic Polymorphisms Implicated in Nonalcoholic Liver Disease or Selected Other Disorders Have No Influence on Drug-Induced Liver Injury.
|
|
Academic Article
|
Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors.
|
|
Academic Article
|
Pilot study of mitochondrial bioenergetics in subjects with acute porphyrias.
|
|
Academic Article
|
Herbal and dietary supplement hepatotoxicity.
|
|
Academic Article
|
Sex differences in vascular reactivity in mesenteric arteries from a mouse model of acute intermittent porphyria.
|
|
Academic Article
|
Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria.
|
|
Academic Article
|
Acute Hepatic Porphyrias: Review and Recent Progress.
|
|
Academic Article
|
Strong correlation of ferrochelatase enzymatic activity with Mitoferrin-1 mRNA in lymphoblasts of patients with protoporphyria.
|
|
Academic Article
|
Baseline Hepatic Levels of miR-29b and Claudin are Respectively Associated with the Stage of Fibrosis and HCV RNA in Hepatitis C.
|
|
Academic Article
|
Benefits of prophylactic heme therapy in severe acute intermittent porphyria.
|